Ankylosing spondylitis (AS) is a chronic inflammatory disorder characterized by dysregulated T cells. We hypothesized that the aberrant expression of microRNAs (miRNAs) in T cells might involve in the pathogenesis of AS. The expression profile of 270 miRNAs in T cells from five AS patients and five healthy controls were analyzed by real-time PCR. After initial analysis, thirteen miRNAs were found potential differentially expression. After validation using 22 AS patients and 18 healthy controls, we confirmed that miR-16, miR-221 and let-7i were overexpressed in AS T cells and their expression levels were positively correlated with the Bath Ankylosing Spondylitis Radiology Index of lumbar spine in AS patients. In addition, the protein molecules regulated by miR-16, miR-221 and let-7i were measured by Western blotting. We found that the protein levels of Toll-like receptor 4 (TLR4), a target of let-7i, in T cells from AS patients were decreased. Lipopolysaccharide (LPS), a TLR4 agonist, inhibited interferon gamma (IFN-γ) secretion by anti-CD3+ anti-CD28 antibodies-stimulated T cells from healthy controls but not AS patients. After transfection of let-7i into normal T cells, LPS promoted IFN-γ production after stimulated by anti-CD3+anti-CD28 antibodies, but the transfection of let-7i does not have effects on IFN-γ production in AS T cells. In summary, we found that miR-16, miR-221, and let-7i were overexpressed in AS T cells and their expression levels were associated with radiographic change. In the functional study, the increased let-7i expression facilitated the Th1 (IFN-γ) immune response in AS T cells.
37th Congress of IUPS (Birmingham, UK) (2013) Proc 37th IUPS, PCA198
Poster Communications: MicroRNA let-7i can control TLR4 expression and affect IFN-╬│ secretion in T cells from patients with ankylosing spondylitis
H. Yu1,2, W. Liu1, N. Lai2,3, H. Chen4, C. Yu5, M. Lu2,3, H. Huang1
1. Department of Life Science and Institute of Molecular Biology, National Chung Cheng University, Chia-Yi, Taiwan. 2. Division of Allergy, Immunology and Rheumatology, Buddhist Dalin Tzu Chi General Hospital, Chia-Yi, Taiwan. 3. School of Medicine, Tzu Chi University, Hualien, Taiwan. 4. Department of Biomedical Sciences, Chang Gung University, Tao-Yuan, Taiwan. 5. Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
View other abstracts by:
Where applicable, experiments conform with Society ethical requirements.